Point72 Asset Management, L.P.

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1603466 STAMFORD, CT

Position in PLRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$59,288

+$2,513 QoQ

Shares Held

47,054

+1.1% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. PLRX ranks #176 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$59,288	47,054	+1.1%	Shares	Defined	2026-05-15
2025-12-31	$56,775	46,537	-98.9%	Shares	Defined	2026-02-17
2025-09-30	$6,420,823	4,338,394	+6.2%	Shares	Defined	2025-11-14
2025-08-27	$6,903,678	4,085,017	+42026.6%	Shares	Sole	2025-09-04
2023-03-31	$257,940	9,697	-98.0%	Shares	Defined	2023-05-15
2022-06-30	$3,881,037	484,524	-37.1%	Shares	Defined	2022-08-15
2022-03-31	$5,397,700	770,000	-32.2%	Shares	Defined	2022-05-16
2021-12-31	$15,323,850	1,135,100	+2104.1%	Shares	Defined	2022-02-14
2020-09-30	$1,166,475	51,500	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.